Key findings were the male predominance in the NAFLD subset, as well as higher BMI, abdominal fat, and insulin resistance (quantified by HOMA-IR), and increased blood insulin, HbA1c, triglycerides, uric acid, transaminases, γGT, ferritin, and creatinine levels and lower serum HDL cholesterol concentrations. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.